Literature DB >> 23735456

Pain and health-related quality of life in people with chronic leg ulcers.

W M Hopman1, M Buchanan, E G VanDenKerkhof, M B Harrison.   

Abstract

INTRODUCTION: Venous leg ulceration is associated with pain and poor health-related quality of life (HRQL). The purpose of this study was to identify demographic and clinical characteristics associated with pain and decreased HRQL in patients with active venous ulcers.
METHODS: Baseline data were combined from two trials that took place between 2001 and 2007 (n = 564). Pain was measured using the Numeric Pain Scale (NPS), and HRQL was measured using the Medical Outcomes Survey 12-item Short Form (SF-12), which generates a Physical (PCS) and Mental Component Summary (MCS). Analyses included logistic and linear regression (for pain and HRQL, respectively).
RESULTS: Mean age was 66.5 years; 47% were male. Median NPS score was 2.2 (out of 10) and mean PCS and MCS scores were 38.0 and 50.5, respectively (scores are standardized to a mean of 50 representing average HRQL). Younger age, living with others, and arthritis were associated with pain. Poorer PCS was associated with being female, venous/mixed ulcer etiology, larger ulcers, longer ulcer duration, cardiovascular disease, arthritis and higher pain intensity. Poorer MCS was associated with younger age, longer ulcer duration, comorbidity and higher pain intensity.
CONCLUSION: Research is needed to test strategies to reduce pain and possibly improve HRQL in high risk groups.

Entities:  

Keywords:  HRQL; Medical Outcomes Survey 12-item Short Form; SF-12; chronic; health-related quality of life; leg ulcers; pain

Mesh:

Year:  2013        PMID: 23735456

Source DB:  PubMed          Journal:  Chronic Dis Inj Can        ISSN: 1925-6515


  8 in total

1.  Factors associated with health-related quality of life in chronic leg ulceration.

Authors:  Wilma M Hopman; Elizabeth G VanDenKerkhof; Meg E Carley; Janet L Kuhnke; Margaret B Harrison
Journal:  Qual Life Res       Date:  2014-01-12       Impact factor: 4.147

2.  Factors associated with quality of life in cutaneous lupus erythematosus using the Revised Wilson and Cleary Model.

Authors:  Motolani E Ogunsanya; Sung Kyung Cho; Andrew Hudson; Benjamin F Chong
Journal:  Lupus       Date:  2020-09-03       Impact factor: 2.911

3.  Safety and performance evaluation of a next-generation antimicrobial dressing in patients with chronic venous leg ulcers.

Authors:  Keith G Harding; Marek Szczepkowski; Jacek Mikosiński; Krystyna Twardowska-Saucha; Stephen Blair; Nicola M Ivins; Wojciech Saucha; Jane Cains; Kim Peters; David Parsons; Philip Bowler
Journal:  Int Wound J       Date:  2015-06-21       Impact factor: 3.315

4.  Extreme pain from brown recluse spider bites: model for cytokine-driven pain.

Authors:  Katie S Payne; Karen Schilli; Katlyn Meier; Ryan K Rader; Jonathan A Dyer; James W Mold; Jonathan A Green; William V Stoecker
Journal:  JAMA Dermatol       Date:  2014-11       Impact factor: 10.282

5.  An observational study protocol to explore loneliness and systemic inflammation in an older adult population with chronic venous leg ulcers.

Authors:  Teresa J Kelechi; Robin C Muise-Helmericks; Laurie A Theeke; Steven W Cole; Mohan Madisetti; Martina Mueller; Margaret A Prentice
Journal:  BMC Geriatr       Date:  2021-02-10       Impact factor: 3.921

6.  Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-06-04

7.  Can Wound Exudate from Venous Leg Ulcers Measure Wound Pain Status?: A Pilot Study.

Authors:  Taichi Goto; Nao Tamai; Gojiro Nakagami; Aya Kitamura; Ayumi Naito; Masayuki Hirokawa; Chisako Shimokawa; Kazuo Takahashi; Junichi Umemoto; Hiromi Sanada
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

8.  Antioxidant dressing therapy versus standard wound care in chronic wounds (the REOX study): study protocol for a randomized controlled trial.

Authors:  Inés María Comino-Sanz; María Dolores López-Franco; Begoña Castro; Pedro Luis Pancorbo-Hidalgo
Journal:  Trials       Date:  2020-06-08       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.